Status:
COMPLETED
Malaria Vaccine Pilot Evaluation
Lead Sponsor:
Rafiq OKINE
Conditions:
Malaria,Falciparum
Feasibility
Eligibility:
All Genders
1-59 years
Brief Summary
The RTS,S/AS01 malaria vaccine is being introduced sub-nationally in phased pilot introductions through the EPI programmes in Malawi Ghana and Kenya. Vaccine introduction is by the respective MoH in s...
Detailed Description
An evaluation of the pilot implementation of RTS,S/AS01 through routine health systems in moderate to high malaria transmission settings in Ghana, Kenya and Malawi. In the context of the new vaccine i...
Eligibility Criteria
Inclusion
- Children aged 1-59 months
Exclusion
- Children aged less than 1 month or greater than 59 months
Key Trial Info
Start Date :
February 25 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2023
Estimated Enrollment :
30124 Patients enrolled
Trial Details
Trial ID
NCT03806465
Start Date
February 25 2019
End Date
July 31 2023
Last Update
December 17 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Kintampo Health Research Centre
Kintampo, Ghana
2
CDC Kenya Malaria Programme
Kisumu, Kenya
3
College of Medicine
Blantyre, Malawi